Ventas (VTR) Aktie Kurs

Ventas Inc is primarily active in the healthcare real estate sector.

Some of the main competitors of Ventas Inc in the market include Welltower Inc and HCP Inc.

Ventas Inc is a renowned company operating in the real estate investment trust (REIT) sector. Established in 1998 and headquartered in Chicago, Illinois, Ventas specializes in healthcare-related properties. They own and manage a diverse portfolio of premium healthcare facilities, including senior housing communities, medical office buildings, hospitals, and skilled nursing facilities. Ventas has played a pivotal role in transforming the healthcare real estate sector through its strategic acquisitions and investments. With a strong commitment to delivering exceptional care environments, Ventas Inc has become a leading name in the industry, offering investors an opportunity to participate in this thriving sector.

Some significant milestones achieved by Ventas Inc include becoming the first healthcare real estate investment trust (REIT) to be listed on the New York Stock Exchange in 1999. The company also expanded its portfolio through strategic acquisitions, such as the $7.2 billion merger with Nationwide Health Properties in 2011. Additionally, Ventas Inc consistently demonstrated strong financial performance, increasing its annual dividend for 19 consecutive years. The company's commitment to long-term growth and its focus on providing quality healthcare real estate solutions have made Ventas Inc a leader in the industry.

Ventas Inc is primarily present in the United States.

Ventas Inc represents a commitment to integrity, innovation, and excellence in the healthcare real estate industry. The company strives to enhance the lives of seniors and other patients by providing high-quality and transformative healthcare environments. With a focus on sustainable growth and generating long-term value for stakeholders, Ventas Inc employs a philosophy of collaboration, transparency, and ethical business practices. By consistently delivering innovative solutions and maintaining strong relationships with its tenants and partners, Ventas Inc continues to lead the way in the healthcare real estate sector.

Analytikere sætter i øjeblikket et gennemsnitligt kursmål på 98,85 USD for Ventas-aktien (median: 99,00 USD), svarende til +11,0 % i forhold til seneste kurs. Konsensus bygger på 27 analytikervurderinger.

Ventas Analytikerens Kursmål 2026

27 analytikere vurderer i øjeblikket Ventas-aktien: 22 anbefaler køb, 5 hold og 0 salg. For 2026 forventer analytikere, at Ventas genererer omsætning på 6,95 Mrd. USD og indtjening pr. aktie på 0,56 USD.

Ventas Analytikerens Kursmål 2026

Omregnet til den aktuelle valutakurs handles Ventas-aktien til 79,79 EUR (89,04 USD).

Ventas-aktien (VTR) er noteret på 7 børser, herunder: NYSE (VTR), London (0LO4.L), SIX (Zürich) (VEN.SW), Frankfurt (VEN.F), München (VEN.MU), Düsseldorf (VEN.DU).

Ventas Inc is a US-based company specializing in healthcare real estate investments. Its business model is based on acquiring and managing properties used by healthcare and senior living facilities. The company is divided into three business segments: Senior Housing Operating Portfolio (SHOP), Medical Office Buildings (MOB), and Life Science Properties (LSP). SHOP includes a wide range of nursing homes and elderly care facilities. Ventas Inc acquires these properties either through facility purchases or by acquiring concession contracts from operators. The company directly operates approximately 110 facilities, making SHOP its highest revenue-generating segment. The MOB segment focuses on acquiring properties used by medical facilities such as doctor's offices, laboratories, and surgical centers. These facilities are often located in complex buildings or campus-like environments and often offer services such as pharmacies, radiology, and rehabilitation. LSP focuses on the real estate needs of life science companies, including biopharmaceutical, biotechnology, and diagnostic companies. The complexity of the properties developed for life science companies requires a high level of expertise and flexibility. Ventas Inc also provides financing and capital structures for the development or acquisition of properties in the SHOP, MOB, and LSP segments. These financing offerings can be tailored to the specific needs of facilities and operators and also include partnerships with other investors. Ventas Inc strives to ensure high-quality and continuous care for patients in its healthcare market through the provision of real estate and financing. The company also emphasizes a long-term growth strategy focused on strengthening operational performance and financial metrics. Overall, Ventas Inc's business model demonstrates a consistent focus on the increasingly important healthcare industry and the needs of patients. With a wide range of real estate offerings and financing options, the company is well-positioned to drive industry growth.

forventet-omsætningen for Ventas er 6,95 Mrd. USD. Dette tal er baseret på aktuelle finansielle data og afspejler virksomhedens forretningsydeevne.

forventet-overskuddet for Ventas er 270,76 Mio. USD. Nettooverskuddet afspejler virksomhedens rentabilitet efter fradrag af alle udgifter.

Pris-til-indtjening-forholdet (P/E) for Ventas er i øjeblikket 158,10. P/E-forholdet sammenligner den nuværende aktiekurs med indtjeningen pr. aktie og hjælper investorer med at vurdere værdiansættelsen af Ventas-aktien.

Pris-til-salgs-forholdet (P/S) for Ventas er i øjeblikket 6,16. P/S-forholdet sammenligner markedskapitalisering med årlig omsætning og fungerer som en værdiansættelsesmetrik for Ventas-aktien.

AlleAktien-kvalitetsscore for Ventas er 4/10.

ISIN for Ventas er US92276F1003. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.

WKN for Ventas er 878380. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.

Tickeren for Ventas er VTR. Tickersymbolet bruges til at handle Ventas-aktier på børsen.